nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2A6—Methoxsalen—psoriasis	0.0652	0.0985	CbGbCtD
Selegiline—CYP2C8—Tazarotene—psoriasis	0.0499	0.0754	CbGbCtD
Selegiline—CYP1A2—Clobetasol propionate—psoriasis	0.0474	0.0716	CbGbCtD
Selegiline—CYP2A6—Prednisolone—psoriasis	0.0317	0.0479	CbGbCtD
Selegiline—CYP2B6—Cholecalciferol—psoriasis	0.0281	0.0425	CbGbCtD
Selegiline—CYP1A2—Methoxsalen—psoriasis	0.0249	0.0376	CbGbCtD
Selegiline—CYP2D6—Hydroxyurea—psoriasis	0.0224	0.0339	CbGbCtD
Selegiline—CYP2C8—Cholecalciferol—psoriasis	0.0213	0.0322	CbGbCtD
Selegiline—CYP2A6—Dexamethasone—psoriasis	0.0187	0.0282	CbGbCtD
Selegiline—CYP2C8—Mycophenolate mofetil—psoriasis	0.0185	0.0279	CbGbCtD
Selegiline—CYP2C19—Cholecalciferol—psoriasis	0.0179	0.027	CbGbCtD
Selegiline—CYP3A4—Calcitriol—psoriasis	0.0168	0.0253	CbGbCtD
Selegiline—CYP2C9—Cholecalciferol—psoriasis	0.0149	0.0224	CbGbCtD
Selegiline—CYP2C8—Hydrocortisone—psoriasis	0.0148	0.0224	CbGbCtD
Selegiline—CYP2C8—Cyclosporine—psoriasis	0.014	0.0211	CbGbCtD
Selegiline—CYP2D6—Cholecalciferol—psoriasis	0.0136	0.0205	CbGbCtD
Selegiline—CYP3A4—Methoxsalen—psoriasis	0.013	0.0197	CbGbCtD
Selegiline—ABCB1—Mycophenolate mofetil—psoriasis	0.0125	0.0189	CbGbCtD
Selegiline—CYP2C19—Prednisone—psoriasis	0.0124	0.0187	CbGbCtD
Selegiline—CYP2E1—Dexamethasone—psoriasis	0.0123	0.0186	CbGbCtD
Selegiline—CYP2B6—Dexamethasone—psoriasis	0.0122	0.0184	CbGbCtD
Selegiline—CYP2C19—Cyclosporine—psoriasis	0.0117	0.0177	CbGbCtD
Selegiline—ABCB1—Betamethasone—psoriasis	0.0107	0.0162	CbGbCtD
Selegiline—ABCB1—Prednisolone—psoriasis	0.0106	0.016	CbGbCtD
Selegiline—ABCB1—Hydrocortisone—psoriasis	0.01	0.0152	CbGbCtD
Selegiline—ABCB1—Prednisone—psoriasis	0.01	0.0151	CbGbCtD
Selegiline—CYP2C9—Cyclosporine—psoriasis	0.00977	0.0147	CbGbCtD
Selegiline—ABCB1—Cyclosporine—psoriasis	0.00948	0.0143	CbGbCtD
Selegiline—CYP2C8—Dexamethasone—psoriasis	0.00922	0.0139	CbGbCtD
Selegiline—CYP2D6—Cyclosporine—psoriasis	0.00893	0.0135	CbGbCtD
Selegiline—CYP3A4—Cholecalciferol—psoriasis	0.00864	0.013	CbGbCtD
Selegiline—CYP2C19—Dexamethasone—psoriasis	0.00773	0.0117	CbGbCtD
Selegiline—CYP3A4—Mycophenolate mofetil—psoriasis	0.00749	0.0113	CbGbCtD
Selegiline—CYP3A4—Triamcinolone—psoriasis	0.00749	0.0113	CbGbCtD
Selegiline—CYP2C9—Dexamethasone—psoriasis	0.00643	0.00971	CbGbCtD
Selegiline—CYP3A4—Betamethasone—psoriasis	0.00643	0.00971	CbGbCtD
Selegiline—CYP3A4—Prednisolone—psoriasis	0.00634	0.00958	CbGbCtD
Selegiline—ABCB1—Dexamethasone—psoriasis	0.00624	0.00942	CbGbCtD
Selegiline—CYP3A4—Hydrocortisone—psoriasis	0.00601	0.00908	CbGbCtD
Selegiline—CYP3A4—Prednisone—psoriasis	0.00599	0.00904	CbGbCtD
Selegiline—CYP2D6—Dexamethasone—psoriasis	0.00588	0.00888	CbGbCtD
Selegiline—CYP3A4—Cyclosporine—psoriasis	0.00568	0.00857	CbGbCtD
Selegiline—ABCB1—Methotrexate—psoriasis	0.00502	0.00757	CbGbCtD
Selegiline—CYP3A4—Dexamethasone—psoriasis	0.00374	0.00565	CbGbCtD
Selegiline—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00252	0.0485	CbGpPWpGaD
Selegiline—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00203	0.0391	CbGpPWpGaD
Selegiline—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00199	0.0383	CbGpPWpGaD
Selegiline—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00172	0.0331	CbGpPWpGaD
Selegiline—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00156	0.0301	CbGpPWpGaD
Selegiline—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00153	0.0296	CbGpPWpGaD
Selegiline—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00141	0.0272	CbGpPWpGaD
Selegiline—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.0014	0.027	CbGpPWpGaD
Selegiline—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00132	0.0254	CbGpPWpGaD
Selegiline—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00126	0.0243	CbGpPWpGaD
Selegiline—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00123	0.0238	CbGpPWpGaD
Selegiline—MAOB—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00108	0.0208	CbGpPWpGaD
Selegiline—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00107	0.0205	CbGpPWpGaD
Selegiline—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000951	0.0183	CbGpPWpGaD
Selegiline—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000875	0.0169	CbGpPWpGaD
Selegiline—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000867	0.0167	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL22—psoriasis	0.000745	0.0144	CbGpPWpGaD
Selegiline—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000741	0.0143	CbGpPWpGaD
Selegiline—MAOA—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000677	0.013	CbGpPWpGaD
Selegiline—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000648	0.0125	CbGpPWpGaD
Selegiline—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000639	0.0123	CbGpPWpGaD
Selegiline—MAOB—Biological oxidations—CYP2S1—psoriasis	0.000573	0.011	CbGpPWpGaD
Selegiline—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000572	0.011	CbGpPWpGaD
Selegiline—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000525	0.0101	CbGpPWpGaD
Selegiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000523	0.0101	CbGpPWpGaD
Selegiline—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000516	0.00994	CbGpPWpGaD
Selegiline—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000512	0.00986	CbGpPWpGaD
Selegiline—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000505	0.00973	CbGpPWpGaD
Selegiline—MAOB—Tryptophan metabolism—CAT—psoriasis	0.000494	0.00952	CbGpPWpGaD
Selegiline—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000443	0.00853	CbGpPWpGaD
Selegiline—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000437	0.00841	CbGpPWpGaD
Selegiline—MAOA—Oxidative Stress—CAT—psoriasis	0.000436	0.00841	CbGpPWpGaD
Selegiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000424	0.00816	CbGpPWpGaD
Selegiline—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000415	0.008	CbGpPWpGaD
Selegiline—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000406	0.00782	CbGpPWpGaD
Selegiline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000395	0.00761	CbGpPWpGaD
Selegiline—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00039	0.00751	CbGpPWpGaD
Selegiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000363	0.007	CbGpPWpGaD
Selegiline—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00036	0.00694	CbGpPWpGaD
Selegiline—MAOA—Biological oxidations—CYP2S1—psoriasis	0.000359	0.00692	CbGpPWpGaD
Selegiline—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000359	0.00691	CbGpPWpGaD
Selegiline—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000359	0.00691	CbGpPWpGaD
Selegiline—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000355	0.00685	CbGpPWpGaD
Selegiline—MAOA—Melatonin metabolism and effects—APOE—psoriasis	0.000348	0.00671	CbGpPWpGaD
Selegiline—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00032	0.00617	CbGpPWpGaD
Selegiline—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000308	0.00594	CbGpPWpGaD
Selegiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000308	0.00593	CbGpPWpGaD
Selegiline—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000304	0.00585	CbGpPWpGaD
Selegiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000295	0.00567	CbGpPWpGaD
Selegiline—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000292	0.00563	CbGpPWpGaD
Selegiline—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000279	0.00537	CbGpPWpGaD
Selegiline—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000269	0.00518	CbGpPWpGaD
Selegiline—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000259	0.00499	CbGpPWpGaD
Selegiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00025	0.00481	CbGpPWpGaD
Selegiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00024	0.00463	CbGpPWpGaD
Selegiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000238	0.00458	CbGpPWpGaD
Selegiline—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000235	0.00453	CbGpPWpGaD
Selegiline—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000235	0.00453	CbGpPWpGaD
Selegiline—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000234	0.00452	CbGpPWpGaD
Selegiline—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000225	0.00434	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000223	0.0043	CbGpPWpGaD
Selegiline—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000222	0.00428	CbGpPWpGaD
Selegiline—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.00022	0.00425	CbGpPWpGaD
Selegiline—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000217	0.00419	CbGpPWpGaD
Selegiline—MAOA—Melatonin metabolism and effects—NFKB1—psoriasis	0.000207	0.00399	CbGpPWpGaD
Selegiline—MAOA—Oxidative Stress—NFKB1—psoriasis	0.000202	0.00389	CbGpPWpGaD
Selegiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000193	0.00371	CbGpPWpGaD
Selegiline—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000191	0.00367	CbGpPWpGaD
Selegiline—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.00019	0.00366	CbGpPWpGaD
Selegiline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00019	0.00366	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000188	0.00362	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000183	0.00352	CbGpPWpGaD
Selegiline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000177	0.00341	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—IL13—psoriasis	0.000176	0.00339	CbGpPWpGaD
Selegiline—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.00017	0.00328	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000168	0.00323	CbGpPWpGaD
Selegiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000167	0.00322	CbGpPWpGaD
Selegiline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000165	0.00319	CbGpPWpGaD
Selegiline—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000165	0.00318	CbGpPWpGaD
Selegiline—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000164	0.00316	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000156	0.00301	CbGpPWpGaD
Selegiline—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000155	0.00299	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000155	0.00299	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000154	0.00297	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000153	0.00295	CbGpPWpGaD
Selegiline—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000152	0.00292	CbGpPWpGaD
Selegiline—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000151	0.00291	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000148	0.00285	CbGpPWpGaD
Selegiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000141	0.00272	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000141	0.00272	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL13—psoriasis	0.00014	0.0027	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000133	0.00255	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000131	0.00252	CbGpPWpGaD
Selegiline—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000131	0.00251	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000129	0.00249	CbGpPWpGaD
Selegiline—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000129	0.00248	CbGpPWpGaD
Selegiline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000123	0.00238	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL12B—psoriasis	0.00012	0.00231	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.000117	0.00226	CbGpPWpGaD
Selegiline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000115	0.00222	CbGpPWpGaD
Selegiline—MAOB—Metabolism—NDUFA5—psoriasis	0.000115	0.00222	CbGpPWpGaD
Selegiline—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000114	0.0022	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—IL10—psoriasis	0.00011	0.00212	CbGpPWpGaD
Selegiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000109	0.0021	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000102	0.00197	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000101	0.00194	CbGpPWpGaD
Selegiline—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	9.95e-05	0.00192	CbGpPWpGaD
Selegiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.86e-05	0.0019	CbGpPWpGaD
Selegiline—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	9.81e-05	0.00189	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CYP2S1—psoriasis	9.8e-05	0.00189	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	9.7e-05	0.00187	CbGpPWpGaD
Selegiline—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	9.02e-05	0.00174	CbGpPWpGaD
Selegiline—CYP3A4—Tryptophan metabolism—CAT—psoriasis	8.83e-05	0.0017	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL10—psoriasis	8.78e-05	0.00169	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL4—psoriasis	8.54e-05	0.00164	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—HLA-B—psoriasis	8.35e-05	0.00161	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	8.34e-05	0.00161	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	7.77e-05	0.0015	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—HLA-A—psoriasis	7.74e-05	0.00149	CbGpPWpGaD
Selegiline—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	7.64e-05	0.00147	CbGpPWpGaD
Selegiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.61e-05	0.00147	CbGpPWpGaD
Selegiline—MAOA—Metabolism—NDUFA5—psoriasis	7.23e-05	0.00139	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	7.07e-05	0.00136	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	6.35e-05	0.00122	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP2S1—psoriasis	6.15e-05	0.00118	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—CXCL8—psoriasis	6.03e-05	0.00116	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—NDUFA5—psoriasis	5.61e-05	0.00108	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—JUN—psoriasis	5.6e-05	0.00108	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	5.49e-05	0.00106	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.39e-05	0.00104	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.28e-05	0.00102	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IFNG—psoriasis	5.16e-05	0.000994	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	5.15e-05	0.000992	CbGpPWpGaD
Selegiline—Myalgia—Dexamethasone—psoriasis	4.92e-05	0.000172	CcSEcCtD
Selegiline—Body temperature increased—Cyclosporine—psoriasis	4.91e-05	0.000172	CcSEcCtD
Selegiline—Abdominal pain—Cyclosporine—psoriasis	4.91e-05	0.000172	CcSEcCtD
Selegiline—Anxiety—Betamethasone—psoriasis	4.91e-05	0.000172	CcSEcCtD
Selegiline—Anxiety—Dexamethasone—psoriasis	4.91e-05	0.000172	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.9e-05	0.000943	CbGpPWpGaD
Selegiline—Vomiting—Mycophenolic acid—psoriasis	4.88e-05	0.000171	CcSEcCtD
Selegiline—Discomfort—Dexamethasone—psoriasis	4.86e-05	0.00017	CcSEcCtD
Selegiline—Discomfort—Betamethasone—psoriasis	4.86e-05	0.00017	CcSEcCtD
Selegiline—Dyspepsia—Hydrocortisone—psoriasis	4.86e-05	0.00017	CcSEcCtD
Selegiline—Rash—Mycophenolic acid—psoriasis	4.84e-05	0.000169	CcSEcCtD
Selegiline—Dermatitis—Mycophenolic acid—psoriasis	4.84e-05	0.000169	CcSEcCtD
Selegiline—Pain—Prednisolone—psoriasis	4.84e-05	0.000169	CcSEcCtD
Selegiline—Hepatitis—Methotrexate—psoriasis	4.83e-05	0.000169	CcSEcCtD
Selegiline—Urticaria—Mycophenolate mofetil—psoriasis	4.82e-05	0.000169	CcSEcCtD
Selegiline—Headache—Mycophenolic acid—psoriasis	4.81e-05	0.000168	CcSEcCtD
Selegiline—Decreased appetite—Hydrocortisone—psoriasis	4.8e-05	0.000168	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—CXCL8—psoriasis	4.8e-05	0.000924	CbGpPWpGaD
Selegiline—Pharyngitis—Methotrexate—psoriasis	4.8e-05	0.000168	CcSEcCtD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.8e-05	0.000924	CbGpPWpGaD
Selegiline—Abdominal pain—Mycophenolate mofetil—psoriasis	4.79e-05	0.000168	CcSEcCtD
Selegiline—Body temperature increased—Mycophenolate mofetil—psoriasis	4.79e-05	0.000168	CcSEcCtD
Selegiline—MAOB—Metabolism—CARM1—psoriasis	4.78e-05	0.000921	CbGpPWpGaD
Selegiline—Urinary tract disorder—Methotrexate—psoriasis	4.77e-05	0.000167	CcSEcCtD
Selegiline—CYP2A6—Metabolism—CYP2S1—psoriasis	4.77e-05	0.000919	CbGpPWpGaD
Selegiline—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.77e-05	0.000167	CcSEcCtD
Selegiline—Fatigue—Hydrocortisone—psoriasis	4.76e-05	0.000167	CcSEcCtD
Selegiline—Vision blurred—Prednisone—psoriasis	4.75e-05	0.000166	CcSEcCtD
Selegiline—Urethral disorder—Methotrexate—psoriasis	4.74e-05	0.000166	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.74e-05	0.000166	CcSEcCtD
Selegiline—Pain—Hydrocortisone—psoriasis	4.72e-05	0.000165	CcSEcCtD
Selegiline—Oedema—Betamethasone—psoriasis	4.72e-05	0.000165	CcSEcCtD
Selegiline—Oedema—Dexamethasone—psoriasis	4.72e-05	0.000165	CcSEcCtD
Selegiline—Insomnia—Triamcinolone—psoriasis	4.7e-05	0.000165	CcSEcCtD
Selegiline—Infection—Dexamethasone—psoriasis	4.69e-05	0.000164	CcSEcCtD
Selegiline—Infection—Betamethasone—psoriasis	4.69e-05	0.000164	CcSEcCtD
Selegiline—Ill-defined disorder—Prednisone—psoriasis	4.67e-05	0.000163	CcSEcCtD
Selegiline—Paraesthesia—Triamcinolone—psoriasis	4.67e-05	0.000163	CcSEcCtD
Selegiline—Feeling abnormal—Prednisolone—psoriasis	4.66e-05	0.000163	CcSEcCtD
Selegiline—Visual impairment—Methotrexate—psoriasis	4.66e-05	0.000163	CcSEcCtD
Selegiline—Anaemia—Prednisone—psoriasis	4.65e-05	0.000163	CcSEcCtD
Selegiline—Shock—Betamethasone—psoriasis	4.64e-05	0.000162	CcSEcCtD
Selegiline—Shock—Dexamethasone—psoriasis	4.64e-05	0.000162	CcSEcCtD
Selegiline—Dyspnoea—Triamcinolone—psoriasis	4.64e-05	0.000162	CcSEcCtD
Selegiline—Nervous system disorder—Betamethasone—psoriasis	4.63e-05	0.000162	CcSEcCtD
Selegiline—Nervous system disorder—Dexamethasone—psoriasis	4.63e-05	0.000162	CcSEcCtD
Selegiline—Agitation—Prednisone—psoriasis	4.63e-05	0.000162	CcSEcCtD
Selegiline—Thrombocytopenia—Dexamethasone—psoriasis	4.62e-05	0.000162	CcSEcCtD
Selegiline—Thrombocytopenia—Betamethasone—psoriasis	4.62e-05	0.000162	CcSEcCtD
Selegiline—Tachycardia—Dexamethasone—psoriasis	4.61e-05	0.000161	CcSEcCtD
Selegiline—Tachycardia—Betamethasone—psoriasis	4.61e-05	0.000161	CcSEcCtD
Selegiline—Hypersensitivity—Cyclosporine—psoriasis	4.58e-05	0.00016	CcSEcCtD
Selegiline—Dyspepsia—Triamcinolone—psoriasis	4.58e-05	0.00016	CcSEcCtD
Selegiline—Nausea—Mycophenolic acid—psoriasis	4.56e-05	0.00016	CcSEcCtD
Selegiline—Hyperhidrosis—Dexamethasone—psoriasis	4.56e-05	0.00016	CcSEcCtD
Selegiline—Hyperhidrosis—Betamethasone—psoriasis	4.56e-05	0.00016	CcSEcCtD
Selegiline—Feeling abnormal—Hydrocortisone—psoriasis	4.55e-05	0.000159	CcSEcCtD
Selegiline—Malaise—Prednisone—psoriasis	4.54e-05	0.000159	CcSEcCtD
Selegiline—CYP2B6—Metabolism—NDUFA5—psoriasis	4.53e-05	0.000872	CbGpPWpGaD
Selegiline—Vertigo—Prednisone—psoriasis	4.52e-05	0.000158	CcSEcCtD
Selegiline—Gastrointestinal pain—Hydrocortisone—psoriasis	4.52e-05	0.000158	CcSEcCtD
Selegiline—Syncope—Prednisone—psoriasis	4.52e-05	0.000158	CcSEcCtD
Selegiline—Tinnitus—Methotrexate—psoriasis	4.51e-05	0.000158	CcSEcCtD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	4.5e-05	0.000867	CbGpPWpGaD
Selegiline—Anorexia—Betamethasone—psoriasis	4.5e-05	0.000157	CcSEcCtD
Selegiline—Anorexia—Dexamethasone—psoriasis	4.5e-05	0.000157	CcSEcCtD
Selegiline—Urticaria—Prednisolone—psoriasis	4.49e-05	0.000157	CcSEcCtD
Selegiline—Fatigue—Triamcinolone—psoriasis	4.48e-05	0.000157	CcSEcCtD
Selegiline—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.47e-05	0.000156	CcSEcCtD
Selegiline—Asthenia—Cyclosporine—psoriasis	4.46e-05	0.000156	CcSEcCtD
Selegiline—Pain—Triamcinolone—psoriasis	4.45e-05	0.000156	CcSEcCtD
Selegiline—CYP2E1—Metabolism—NDUFA5—psoriasis	4.43e-05	0.000854	CbGpPWpGaD
Selegiline—Loss of consciousness—Prednisone—psoriasis	4.43e-05	0.000155	CcSEcCtD
Selegiline—Hypotension—Betamethasone—psoriasis	4.41e-05	0.000154	CcSEcCtD
Selegiline—Hypotension—Dexamethasone—psoriasis	4.41e-05	0.000154	CcSEcCtD
Selegiline—Pruritus—Cyclosporine—psoriasis	4.4e-05	0.000154	CcSEcCtD
Selegiline—Urticaria—Hydrocortisone—psoriasis	4.39e-05	0.000154	CcSEcCtD
Selegiline—Angiopathy—Methotrexate—psoriasis	4.39e-05	0.000153	CcSEcCtD
Selegiline—Body temperature increased—Hydrocortisone—psoriasis	4.37e-05	0.000153	CcSEcCtD
Selegiline—Abdominal pain—Hydrocortisone—psoriasis	4.37e-05	0.000153	CcSEcCtD
Selegiline—Convulsion—Prednisone—psoriasis	4.36e-05	0.000153	CcSEcCtD
Selegiline—Asthenia—Mycophenolate mofetil—psoriasis	4.35e-05	0.000152	CcSEcCtD
Selegiline—Hypertension—Prednisone—psoriasis	4.35e-05	0.000152	CcSEcCtD
Selegiline—Chills—Methotrexate—psoriasis	4.34e-05	0.000152	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Betamethasone—psoriasis	4.3e-05	0.00015	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.3e-05	0.00015	CcSEcCtD
Selegiline—Pruritus—Mycophenolate mofetil—psoriasis	4.29e-05	0.00015	CcSEcCtD
Selegiline—Myalgia—Prednisone—psoriasis	4.29e-05	0.00015	CcSEcCtD
Selegiline—Arthralgia—Prednisone—psoriasis	4.29e-05	0.00015	CcSEcCtD
Selegiline—Feeling abnormal—Triamcinolone—psoriasis	4.29e-05	0.00015	CcSEcCtD
Selegiline—Anxiety—Prednisone—psoriasis	4.27e-05	0.000149	CcSEcCtD
Selegiline—Alopecia—Methotrexate—psoriasis	4.27e-05	0.000149	CcSEcCtD
Selegiline—Insomnia—Betamethasone—psoriasis	4.27e-05	0.000149	CcSEcCtD
Selegiline—Insomnia—Dexamethasone—psoriasis	4.27e-05	0.000149	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.26e-05	0.000149	CcSEcCtD
Selegiline—Diarrhoea—Cyclosporine—psoriasis	4.25e-05	0.000149	CcSEcCtD
Selegiline—Paraesthesia—Dexamethasone—psoriasis	4.24e-05	0.000148	CcSEcCtD
Selegiline—Paraesthesia—Betamethasone—psoriasis	4.24e-05	0.000148	CcSEcCtD
Selegiline—Discomfort—Prednisone—psoriasis	4.24e-05	0.000148	CcSEcCtD
Selegiline—Mental disorder—Methotrexate—psoriasis	4.24e-05	0.000148	CcSEcCtD
Selegiline—Malnutrition—Methotrexate—psoriasis	4.21e-05	0.000147	CcSEcCtD
Selegiline—Erythema—Methotrexate—psoriasis	4.21e-05	0.000147	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—TNF—psoriasis	4.2e-05	0.000808	CbGpPWpGaD
Selegiline—Hypersensitivity—Prednisolone—psoriasis	4.17e-05	0.000146	CcSEcCtD
Selegiline—Dyspepsia—Betamethasone—psoriasis	4.15e-05	0.000145	CcSEcCtD
Selegiline—Dyspepsia—Dexamethasone—psoriasis	4.15e-05	0.000145	CcSEcCtD
Selegiline—Diarrhoea—Mycophenolate mofetil—psoriasis	4.15e-05	0.000145	CcSEcCtD
Selegiline—Urticaria—Triamcinolone—psoriasis	4.13e-05	0.000145	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—psoriasis	4.12e-05	0.000144	CcSEcCtD
Selegiline—Body temperature increased—Triamcinolone—psoriasis	4.11e-05	0.000144	CcSEcCtD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.11e-05	0.000792	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.11e-05	0.000792	CbGpPWpGaD
Selegiline—Dizziness—Cyclosporine—psoriasis	4.11e-05	0.000144	CcSEcCtD
Selegiline—Oedema—Prednisone—psoriasis	4.11e-05	0.000144	CcSEcCtD
Selegiline—Decreased appetite—Dexamethasone—psoriasis	4.1e-05	0.000144	CcSEcCtD
Selegiline—Decreased appetite—Betamethasone—psoriasis	4.1e-05	0.000144	CcSEcCtD
Selegiline—Infection—Prednisone—psoriasis	4.08e-05	0.000143	CcSEcCtD
Selegiline—Gastrointestinal disorder—Dexamethasone—psoriasis	4.07e-05	0.000143	CcSEcCtD
Selegiline—Gastrointestinal disorder—Betamethasone—psoriasis	4.07e-05	0.000143	CcSEcCtD
Selegiline—Back pain—Methotrexate—psoriasis	4.07e-05	0.000142	CcSEcCtD
Selegiline—Hypersensitivity—Hydrocortisone—psoriasis	4.07e-05	0.000142	CcSEcCtD
Selegiline—Fatigue—Dexamethasone—psoriasis	4.07e-05	0.000142	CcSEcCtD
Selegiline—Fatigue—Betamethasone—psoriasis	4.07e-05	0.000142	CcSEcCtD
Selegiline—Shock—Prednisone—psoriasis	4.04e-05	0.000141	CcSEcCtD
Selegiline—Pain—Betamethasone—psoriasis	4.04e-05	0.000141	CcSEcCtD
Selegiline—Pain—Dexamethasone—psoriasis	4.04e-05	0.000141	CcSEcCtD
Selegiline—Nervous system disorder—Prednisone—psoriasis	4.03e-05	0.000141	CcSEcCtD
Selegiline—Tachycardia—Prednisone—psoriasis	4.01e-05	0.00014	CcSEcCtD
Selegiline—Dizziness—Mycophenolate mofetil—psoriasis	4.01e-05	0.00014	CcSEcCtD
Selegiline—Skin disorder—Prednisone—psoriasis	3.99e-05	0.00014	CcSEcCtD
Selegiline—Hyperhidrosis—Prednisone—psoriasis	3.97e-05	0.000139	CcSEcCtD
Selegiline—Vision blurred—Methotrexate—psoriasis	3.97e-05	0.000139	CcSEcCtD
Selegiline—Asthenia—Hydrocortisone—psoriasis	3.96e-05	0.000139	CcSEcCtD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.95e-05	0.000761	CbGpPWpGaD
Selegiline—Vomiting—Cyclosporine—psoriasis	3.95e-05	0.000138	CcSEcCtD
Selegiline—Rash—Cyclosporine—psoriasis	3.92e-05	0.000137	CcSEcCtD
Selegiline—Anorexia—Prednisone—psoriasis	3.92e-05	0.000137	CcSEcCtD
Selegiline—Dermatitis—Cyclosporine—psoriasis	3.92e-05	0.000137	CcSEcCtD
Selegiline—Pruritus—Hydrocortisone—psoriasis	3.91e-05	0.000137	CcSEcCtD
Selegiline—Ill-defined disorder—Methotrexate—psoriasis	3.9e-05	0.000137	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.9e-05	0.000751	CbGpPWpGaD
Selegiline—Headache—Cyclosporine—psoriasis	3.89e-05	0.000136	CcSEcCtD
Selegiline—Anaemia—Methotrexate—psoriasis	3.89e-05	0.000136	CcSEcCtD
Selegiline—Feeling abnormal—Betamethasone—psoriasis	3.89e-05	0.000136	CcSEcCtD
Selegiline—Feeling abnormal—Dexamethasone—psoriasis	3.89e-05	0.000136	CcSEcCtD
Selegiline—Gastrointestinal pain—Dexamethasone—psoriasis	3.86e-05	0.000135	CcSEcCtD
Selegiline—Gastrointestinal pain—Betamethasone—psoriasis	3.86e-05	0.000135	CcSEcCtD
Selegiline—Vomiting—Mycophenolate mofetil—psoriasis	3.85e-05	0.000135	CcSEcCtD
Selegiline—CYP2B6—Metabolism—CYP2S1—psoriasis	3.85e-05	0.000742	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NDUFA5—psoriasis	3.83e-05	0.000738	CbGpPWpGaD
Selegiline—Hypersensitivity—Triamcinolone—psoriasis	3.83e-05	0.000134	CcSEcCtD
Selegiline—Rash—Mycophenolate mofetil—psoriasis	3.82e-05	0.000134	CcSEcCtD
Selegiline—Dermatitis—Mycophenolate mofetil—psoriasis	3.82e-05	0.000134	CcSEcCtD
Selegiline—Headache—Mycophenolate mofetil—psoriasis	3.8e-05	0.000133	CcSEcCtD
Selegiline—Malaise—Methotrexate—psoriasis	3.8e-05	0.000133	CcSEcCtD
Selegiline—Vertigo—Methotrexate—psoriasis	3.78e-05	0.000132	CcSEcCtD
Selegiline—Diarrhoea—Hydrocortisone—psoriasis	3.78e-05	0.000132	CcSEcCtD
Selegiline—CYP2E1—Metabolism—CYP2S1—psoriasis	3.77e-05	0.000726	CbGpPWpGaD
Selegiline—Leukopenia—Methotrexate—psoriasis	3.77e-05	0.000132	CcSEcCtD
Selegiline—Urticaria—Dexamethasone—psoriasis	3.75e-05	0.000131	CcSEcCtD
Selegiline—Urticaria—Betamethasone—psoriasis	3.75e-05	0.000131	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Prednisone—psoriasis	3.74e-05	0.000131	CcSEcCtD
Selegiline—Dizziness—Prednisolone—psoriasis	3.74e-05	0.000131	CcSEcCtD
Selegiline—Asthenia—Triamcinolone—psoriasis	3.73e-05	0.000131	CcSEcCtD
Selegiline—Abdominal pain—Dexamethasone—psoriasis	3.73e-05	0.000131	CcSEcCtD
Selegiline—Body temperature increased—Dexamethasone—psoriasis	3.73e-05	0.000131	CcSEcCtD
Selegiline—Body temperature increased—Betamethasone—psoriasis	3.73e-05	0.000131	CcSEcCtD
Selegiline—Abdominal pain—Betamethasone—psoriasis	3.73e-05	0.000131	CcSEcCtD
Selegiline—Insomnia—Prednisone—psoriasis	3.72e-05	0.00013	CcSEcCtD
Selegiline—Nausea—Cyclosporine—psoriasis	3.69e-05	0.000129	CcSEcCtD
Selegiline—Paraesthesia—Prednisone—psoriasis	3.69e-05	0.000129	CcSEcCtD
Selegiline—Pruritus—Triamcinolone—psoriasis	3.68e-05	0.000129	CcSEcCtD
Selegiline—Cough—Methotrexate—psoriasis	3.67e-05	0.000128	CcSEcCtD
Selegiline—Dizziness—Hydrocortisone—psoriasis	3.65e-05	0.000128	CcSEcCtD
Selegiline—Convulsion—Methotrexate—psoriasis	3.65e-05	0.000128	CcSEcCtD
Selegiline—Dyspepsia—Prednisone—psoriasis	3.62e-05	0.000127	CcSEcCtD
Selegiline—Nausea—Mycophenolate mofetil—psoriasis	3.6e-05	0.000126	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—psoriasis	3.58e-05	0.000125	CcSEcCtD
Selegiline—Chest pain—Methotrexate—psoriasis	3.58e-05	0.000125	CcSEcCtD
Selegiline—Myalgia—Methotrexate—psoriasis	3.58e-05	0.000125	CcSEcCtD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.57e-05	0.000689	CbGpPWpGaD
Selegiline—Decreased appetite—Prednisone—psoriasis	3.57e-05	0.000125	CcSEcCtD
Selegiline—Rash—Prednisolone—psoriasis	3.57e-05	0.000125	CcSEcCtD
Selegiline—Dermatitis—Prednisolone—psoriasis	3.56e-05	0.000125	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.56e-05	0.000124	CcSEcCtD
Selegiline—Fatigue—Prednisone—psoriasis	3.54e-05	0.000124	CcSEcCtD
Selegiline—Headache—Prednisolone—psoriasis	3.54e-05	0.000124	CcSEcCtD
Selegiline—Discomfort—Methotrexate—psoriasis	3.54e-05	0.000124	CcSEcCtD
Selegiline—Constipation—Prednisone—psoriasis	3.51e-05	0.000123	CcSEcCtD
Selegiline—Vomiting—Hydrocortisone—psoriasis	3.51e-05	0.000123	CcSEcCtD
Selegiline—Rash—Hydrocortisone—psoriasis	3.48e-05	0.000122	CcSEcCtD
Selegiline—Dermatitis—Hydrocortisone—psoriasis	3.48e-05	0.000122	CcSEcCtD
Selegiline—Confusional state—Methotrexate—psoriasis	3.46e-05	0.000121	CcSEcCtD
Selegiline—Headache—Hydrocortisone—psoriasis	3.46e-05	0.000121	CcSEcCtD
Selegiline—Dizziness—Triamcinolone—psoriasis	3.44e-05	0.00012	CcSEcCtD
Selegiline—CYP2C19—Metabolism—NDUFA5—psoriasis	3.42e-05	0.000659	CbGpPWpGaD
Selegiline—Infection—Methotrexate—psoriasis	3.41e-05	0.000119	CcSEcCtD
Selegiline—Feeling abnormal—Prednisone—psoriasis	3.39e-05	0.000118	CcSEcCtD
Selegiline—Asthenia—Dexamethasone—psoriasis	3.39e-05	0.000118	CcSEcCtD
Selegiline—Asthenia—Betamethasone—psoriasis	3.39e-05	0.000118	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—IL6—psoriasis	3.39e-05	0.000652	CbGpPWpGaD
Selegiline—Nervous system disorder—Methotrexate—psoriasis	3.37e-05	0.000118	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—psoriasis	3.36e-05	0.000118	CcSEcCtD
Selegiline—Gastrointestinal pain—Prednisone—psoriasis	3.36e-05	0.000118	CcSEcCtD
Selegiline—Nausea—Prednisolone—psoriasis	3.36e-05	0.000118	CcSEcCtD
Selegiline—ABCB1—Allograft Rejection—TNF—psoriasis	3.34e-05	0.000643	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NDUFA5—psoriasis	3.34e-05	0.000643	CbGpPWpGaD
Selegiline—Pruritus—Betamethasone—psoriasis	3.34e-05	0.000117	CcSEcCtD
Selegiline—Pruritus—Dexamethasone—psoriasis	3.34e-05	0.000117	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—psoriasis	3.34e-05	0.000117	CcSEcCtD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.32e-05	0.00064	CbGpPWpGaD
Selegiline—Hyperhidrosis—Methotrexate—psoriasis	3.32e-05	0.000116	CcSEcCtD
Selegiline—Vomiting—Triamcinolone—psoriasis	3.31e-05	0.000116	CcSEcCtD
Selegiline—Nausea—Hydrocortisone—psoriasis	3.28e-05	0.000115	CcSEcCtD
Selegiline—Rash—Triamcinolone—psoriasis	3.28e-05	0.000115	CcSEcCtD
Selegiline—Dermatitis—Triamcinolone—psoriasis	3.28e-05	0.000115	CcSEcCtD
Selegiline—Anorexia—Methotrexate—psoriasis	3.27e-05	0.000115	CcSEcCtD
Selegiline—Urticaria—Prednisone—psoriasis	3.26e-05	0.000114	CcSEcCtD
Selegiline—CYP2C8—Metabolism—CYP2S1—psoriasis	3.26e-05	0.000628	CbGpPWpGaD
Selegiline—Headache—Triamcinolone—psoriasis	3.26e-05	0.000114	CcSEcCtD
Selegiline—Body temperature increased—Prednisone—psoriasis	3.25e-05	0.000114	CcSEcCtD
Selegiline—Abdominal pain—Prednisone—psoriasis	3.25e-05	0.000114	CcSEcCtD
Selegiline—Diarrhoea—Betamethasone—psoriasis	3.23e-05	0.000113	CcSEcCtD
Selegiline—Diarrhoea—Dexamethasone—psoriasis	3.23e-05	0.000113	CcSEcCtD
Selegiline—Hypotension—Methotrexate—psoriasis	3.21e-05	0.000112	CcSEcCtD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.19e-05	0.000615	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NDUFA5—psoriasis	3.15e-05	0.000606	CbGpPWpGaD
Selegiline—Musculoskeletal discomfort—Methotrexate—psoriasis	3.13e-05	0.000109	CcSEcCtD
Selegiline—Dizziness—Betamethasone—psoriasis	3.12e-05	0.000109	CcSEcCtD
Selegiline—Dizziness—Dexamethasone—psoriasis	3.12e-05	0.000109	CcSEcCtD
Selegiline—CYP2C9—Metabolism—NDUFA5—psoriasis	3.12e-05	0.000601	CbGpPWpGaD
Selegiline—Insomnia—Methotrexate—psoriasis	3.11e-05	0.000109	CcSEcCtD
Selegiline—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.1e-05	0.000598	CbGpPWpGaD
Selegiline—Nausea—Triamcinolone—psoriasis	3.09e-05	0.000108	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—psoriasis	3.08e-05	0.000108	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—psoriasis	3.06e-05	0.000107	CcSEcCtD
Selegiline—Somnolence—Methotrexate—psoriasis	3.05e-05	0.000107	CcSEcCtD
Selegiline—Hypersensitivity—Prednisone—psoriasis	3.03e-05	0.000106	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—psoriasis	3.02e-05	0.000106	CcSEcCtD
Selegiline—MAOA—Metabolism—CARM1—psoriasis	3e-05	0.000578	CbGpPWpGaD
Selegiline—Vomiting—Betamethasone—psoriasis	3e-05	0.000105	CcSEcCtD
Selegiline—Vomiting—Dexamethasone—psoriasis	3e-05	0.000105	CcSEcCtD
Selegiline—Decreased appetite—Methotrexate—psoriasis	2.99e-05	0.000104	CcSEcCtD
Selegiline—Rash—Dexamethasone—psoriasis	2.98e-05	0.000104	CcSEcCtD
Selegiline—Rash—Betamethasone—psoriasis	2.98e-05	0.000104	CcSEcCtD
Selegiline—Dermatitis—Dexamethasone—psoriasis	2.97e-05	0.000104	CcSEcCtD
Selegiline—Dermatitis—Betamethasone—psoriasis	2.97e-05	0.000104	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—psoriasis	2.97e-05	0.000104	CcSEcCtD
Selegiline—Fatigue—Methotrexate—psoriasis	2.96e-05	0.000104	CcSEcCtD
Selegiline—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.96e-05	0.00057	CbGpPWpGaD
Selegiline—Headache—Dexamethasone—psoriasis	2.96e-05	0.000103	CcSEcCtD
Selegiline—Headache—Betamethasone—psoriasis	2.96e-05	0.000103	CcSEcCtD
Selegiline—Asthenia—Prednisone—psoriasis	2.95e-05	0.000103	CcSEcCtD
Selegiline—MAOB—Metabolism—CAT—psoriasis	2.94e-05	0.000567	CbGpPWpGaD
Selegiline—Pain—Methotrexate—psoriasis	2.94e-05	0.000103	CcSEcCtD
Selegiline—CYP2C19—Metabolism—CYP2S1—psoriasis	2.91e-05	0.00056	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.91e-05	0.00056	CbGpPWpGaD
Selegiline—Pruritus—Prednisone—psoriasis	2.91e-05	0.000102	CcSEcCtD
Selegiline—ABCB1—Metabolism—CYP2S1—psoriasis	2.84e-05	0.000547	CbGpPWpGaD
Selegiline—Feeling abnormal—Methotrexate—psoriasis	2.83e-05	9.9e-05	CcSEcCtD
Selegiline—Diarrhoea—Prednisone—psoriasis	2.81e-05	9.84e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—psoriasis	2.81e-05	9.83e-05	CcSEcCtD
Selegiline—Nausea—Betamethasone—psoriasis	2.8e-05	9.81e-05	CcSEcCtD
Selegiline—Nausea—Dexamethasone—psoriasis	2.8e-05	9.81e-05	CcSEcCtD
Selegiline—Urticaria—Methotrexate—psoriasis	2.73e-05	9.55e-05	CcSEcCtD
Selegiline—Dizziness—Prednisone—psoriasis	2.72e-05	9.51e-05	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—psoriasis	2.72e-05	9.5e-05	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—psoriasis	2.72e-05	9.5e-05	CcSEcCtD
Selegiline—CYP2D6—Metabolism—CYP2S1—psoriasis	2.68e-05	0.000515	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NDUFA5—psoriasis	2.67e-05	0.000514	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP2S1—psoriasis	2.65e-05	0.000511	CbGpPWpGaD
Selegiline—Vomiting—Prednisone—psoriasis	2.61e-05	9.14e-05	CcSEcCtD
Selegiline—Rash—Prednisone—psoriasis	2.59e-05	9.07e-05	CcSEcCtD
Selegiline—Dermatitis—Prednisone—psoriasis	2.59e-05	9.06e-05	CcSEcCtD
Selegiline—Headache—Prednisone—psoriasis	2.57e-05	9.01e-05	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—psoriasis	2.53e-05	8.85e-05	CcSEcCtD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.49e-05	0.000479	CbGpPWpGaD
Selegiline—Asthenia—Methotrexate—psoriasis	2.46e-05	8.62e-05	CcSEcCtD
Selegiline—Nausea—Prednisone—psoriasis	2.44e-05	8.54e-05	CcSEcCtD
Selegiline—Pruritus—Methotrexate—psoriasis	2.43e-05	8.5e-05	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—psoriasis	2.35e-05	8.22e-05	CcSEcCtD
Selegiline—CYP2A6—Metabolism—CARM1—psoriasis	2.33e-05	0.000449	CbGpPWpGaD
Selegiline—MAOB—Metabolism—APOE—psoriasis	2.29e-05	0.00044	CbGpPWpGaD
Selegiline—Dizziness—Methotrexate—psoriasis	2.27e-05	7.95e-05	CcSEcCtD
Selegiline—CYP1A2—Metabolism—CYP2S1—psoriasis	2.27e-05	0.000437	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.2e-05	0.000424	CbGpPWpGaD
Selegiline—Vomiting—Methotrexate—psoriasis	2.18e-05	7.64e-05	CcSEcCtD
Selegiline—Rash—Methotrexate—psoriasis	2.17e-05	7.58e-05	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—psoriasis	2.16e-05	7.57e-05	CcSEcCtD
Selegiline—Headache—Methotrexate—psoriasis	2.15e-05	7.53e-05	CcSEcCtD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.12e-05	0.000408	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NDUFA5—psoriasis	2.06e-05	0.000396	CbGpPWpGaD
Selegiline—Nausea—Methotrexate—psoriasis	2.04e-05	7.14e-05	CcSEcCtD
Selegiline—MAOB—Metabolism—PPARG—psoriasis	1.99e-05	0.000384	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.92e-05	0.000371	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CARM1—psoriasis	1.88e-05	0.000362	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CAT—psoriasis	1.85e-05	0.000356	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CARM1—psoriasis	1.84e-05	0.000355	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2S1—psoriasis	1.75e-05	0.000337	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.71e-05	0.000329	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.65e-05	0.000318	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CARM1—psoriasis	1.59e-05	0.000307	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.52e-05	0.000294	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.49e-05	0.000287	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.45e-05	0.00028	CbGpPWpGaD
Selegiline—MAOA—Metabolism—APOE—psoriasis	1.43e-05	0.000276	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CAT—psoriasis	1.43e-05	0.000276	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CARM1—psoriasis	1.42e-05	0.000274	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.39e-05	0.000268	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CARM1—psoriasis	1.39e-05	0.000267	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.33e-05	0.000256	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CARM1—psoriasis	1.31e-05	0.000252	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CARM1—psoriasis	1.3e-05	0.00025	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PPARG—psoriasis	1.25e-05	0.000241	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.21e-05	0.000233	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.19e-05	0.000229	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CAT—psoriasis	1.16e-05	0.000223	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CAT—psoriasis	1.13e-05	0.000218	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—APOE—psoriasis	1.11e-05	0.000215	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CARM1—psoriasis	1.11e-05	0.000213	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.03e-05	0.000199	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CAT—psoriasis	9.79e-06	0.000189	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PPARG—psoriasis	9.7e-06	0.000187	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—APOE—psoriasis	8.99e-06	0.000173	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—APOE—psoriasis	8.8e-06	0.00017	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CAT—psoriasis	8.74e-06	0.000168	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CARM1—psoriasis	8.54e-06	0.000165	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CAT—psoriasis	8.53e-06	0.000164	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CAT—psoriasis	8.04e-06	0.000155	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CAT—psoriasis	7.97e-06	0.000153	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PPARG—psoriasis	7.83e-06	0.000151	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PPARG—psoriasis	7.67e-06	0.000148	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—APOE—psoriasis	7.61e-06	0.000147	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CAT—psoriasis	6.81e-06	0.000131	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—APOE—psoriasis	6.79e-06	0.000131	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—APOE—psoriasis	6.63e-06	0.000128	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PPARG—psoriasis	6.63e-06	0.000128	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—APOE—psoriasis	6.25e-06	0.00012	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—APOE—psoriasis	6.19e-06	0.000119	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PPARG—psoriasis	5.91e-06	0.000114	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PPARG—psoriasis	5.77e-06	0.000111	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PPARG—psoriasis	5.44e-06	0.000105	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PPARG—psoriasis	5.39e-06	0.000104	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—APOE—psoriasis	5.29e-06	0.000102	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CAT—psoriasis	5.25e-06	0.000101	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PPARG—psoriasis	4.61e-06	8.88e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—APOE—psoriasis	4.08e-06	7.87e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PPARG—psoriasis	3.56e-06	6.85e-05	CbGpPWpGaD
